Alterations in the hypothalamic-pituitary-adrenal axis in metabolic syndrome

Endocrinologist

Volumn 11, Issue 6, 2001, Pages 491-497

  Rosmond, Roland ^a,b   Björntorp, Per ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NORADRENALIN;

CARDIOVASCULAR RISK; DEXAMETHASONE SUPPRESSION TEST; HORMONAL REGULATION; HUMAN; HYDROCORTISONE RELEASE; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY; PATHOPHYSIOLOGY; REVIEW; SALIVA ANALYSIS; SYNDROME DELINEATION;

EID: 0035208596     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019616-200111000-00010     Document Type: Review

References (59)

1. The associations between obesity, adipose tissue distribution and disease
2. Banting Lecture 1988. Role of insulin resistance in human disease
3. Visceral obesity and the metabolic syndrome
4. Rhythms of ACTH and corticosteroid secretion in health and disease, and their experimental modification
5. Circadian time-keeping in health and disease. Part 1. Basic properties of circadian pacemakers
6. The relationship between salivary cortisol concentrations in frozen versus mailed samples
7. Salivary cortisol in psychobiological research: An overview
8. Salivary cortisol testing in children
9. Salivary testosterone determination in studies of child health and development
10. Late-night salivary cortisol as a screening test for Cushing's syndrome
11. Out-patient screening for Cushing's syndrome: The sensitivity of the combination of circadian rhythm and overnight dexamethasone suppression salivary cortisol tests
12. Salivary cortisol: A practical method for evaluation of adrenal function
13. Clinical utility of the dexamethasone suppression test assessed by plasma and salivary cortisol determinations
14. Salivary cortisol in psychoneuroendocrine research: Recent developments and applications
15. Stress-related cortisol secretion in men: Relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities
16. Food-induced cortisol secretion in relation to anthropometric, metabolic and haemodynamic variables in men
17. The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke
18. Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing's syndrome
19. The dexamethasone suppression test for melancholia
20. Inhibition of cortisol secretion by dexamethasone in relation to body fat distribution: A dose-response study
21. Endocrine and metabolic aberrations in men with abdominal obesity in relation to anxio-depressive infirmity
22. Stress and the biology of inequality
23. Dexamethasone and 11-dehydrodexamethasone as tools to investigate the isozymes of 11 beta-hydroxysteroid dehydrogenase in vitro and in vivo
24. Reproducibility of the low dose dexamethasone suppression test: Comparison between direct plasma and salivary cortisol assays
25. A healthy body in a healthy mind - And-vice versa - The damaging power of "uncontrollable" stress
26. Stress and the aging hippocampus
27. The influence of occupational and social factors on obesity and body fat distribution in middle-aged men
28. Psychosocial and socio-economic factors in women and their relationship to obesity and regional body fat distribution
29. Occupational status, cortisol secretory pattern, and visceral obesity in middle-aged men
30. Mental distress, obesity and body fat distribution in middle-aged men
31. Psychiatric ill-health of women and its relationship to obesity and body fat distribution
32. Effects of exercise and stress on body fat distribution in male cynomolgus monkeys
33. Behavior and physiology of social stress and depression in female cynomolgus monkeys
34. Abdominal visceral fat is associated with a BclI restriction fragment length polymorphism at the glucocorticoid receptor gene locus
35. A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo
36. High penetrance, overweight, and glucocorticoid receptor variant: Case-control study
37. Tsp5091 polymorphism in exon 2 of the glucocorticoid receptor gene in relation to obesity and cortisol secretion: Cohort study
38. A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamic-pituitary-adrenal axis
39. A polymorphism of the 5′-flanking region of the glucocorticoid receptor gene locus is associated with basal cortisol secretion in men
40. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis
41. Corticotropin-releasing hormone and opioid peptides in reproduction and stress
42. Intrahypothalamic action of corticotrophin-releasing factor (CRF) to inhibit growth hormone and LH release in the rat
43. Paradoxical effect of corticosteroids on pituitary ACTH/beta-endorphin release in stressed animals
44. The pathogenesis of the metabolic syndrome
45. Changes in body composition and adipose tissue distribution after treatment of women with Cushing's syndrome
46. Hypothalamic arousal, insulin resistance and Type 2 diabetes mellitus
47. Serum immunoreactive-leptin concentrations in normal-weight and obese humans
48. Glucocorticoids as counterregulatory hormones of leptin: Toward an understanding of leptin resistance
49. Plasma leptin levels do not change in patients with Cushing's disease shortly after correction of hypercortisolism
50. The interactions between hypothalamic-pituitary-adrenal axis activity, testosterone, insulin-like growth factor I and abdominal obesity with metabolism and blood pressure in men
51. Human leptin levels are pulsatile and inversely related to pituitary-adrenal function
52. CRF initiates biological actions within the brain that are observed in response to stress
53. Sympatho-adrenal medullary functions in response to intracerebroventricularly injected corticotropin-releasing factor in anesthetized rats
54. Participation of alpha 1-adrenergic receptors in the secretion of hypothalamic corticotropin-releasing hormone during stress
55. Activation of central alpha 1-adrenoceptors in humans stimulates secretion of prolactin and TSH, as well as ACTH
56. Involvement of corticotropin-releasing factor in the control of food intake and energy expenditure
57. Blood pressure in relation to obesity, insulin and the hypothalamic-pituitary-adrenal axis in Swedish men
58. The activity of the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system in relation to waist/hip circumference ratio in men
59. Stress update. Adaption of the hypothalamic-pituitary-adrenal axis to chronic stress